180 related articles for article (PubMed ID: 14630616)
1. Maternal and personal cigarette smoking synergize to increase airflow limitation in adults.
Upton MN; Smith GD; McConnachie A; Hart CL; Watt GC
Am J Respir Crit Care Med; 2004 Feb; 169(4):479-87. PubMed ID: 14630616
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of airflow limitation among employees in Norwegian smelters: a longitudinal study.
Søyseth V; Johnsen HL; Bugge MD; Hetland SM; Kongerud J
Occup Environ Med; 2011 Jan; 68(1):24-9. PubMed ID: 20798007
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
4. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
Medbø A; Melbye H
Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
[TBL] [Abstract][Full Text] [Related]
5. Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction?
Hansen JE; Sun XG; Wasserman K
Eur Respir J; 2006 Jun; 27(6):1244-50. PubMed ID: 16455822
[TBL] [Abstract][Full Text] [Related]
6. Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: the Takahata study.
Osaka D; Shibata Y; Abe S; Inoue S; Tokairin Y; Igarashi A; Yamauchi K; Kimura T; Sato M; Kishi H; Takabatake N; Sata M; Watanabe T; Konta T; Kawata S; Kato T; Kubota I
Intern Med; 2010; 49(15):1489-99. PubMed ID: 20686279
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease].
Zhang FQ; Zheng JP; Wang JH; Lu WB; Wu RX; Li XS; Xian QZ; Gao Y; Jiang M
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):109-13. PubMed ID: 20367950
[TBL] [Abstract][Full Text] [Related]
8. Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease.
Yanbaeva DG; Wouters EF; Dentener MA; Spruit MA; Reynaert NL
Free Radic Res; 2009 Aug; 43(8):738-43. PubMed ID: 19513904
[TBL] [Abstract][Full Text] [Related]
9. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese.
Lam DC; Fong DY; Yu WC; Ko FW; Lau AC; Chan JW; Choo KL; Mok TY; Tam CY; Ip MS; Chan-Yeung MM
Int J Tuberc Lung Dis; 2012 May; 16(5):681-6. PubMed ID: 22507932
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
[TBL] [Abstract][Full Text] [Related]
11. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
[TBL] [Abstract][Full Text] [Related]
12. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
[TBL] [Abstract][Full Text] [Related]
13. Lung function and exposure to workplace second-hand smoke during exemptions from smoking ban legislation: an exposure-response relationship based on indoor PM2.5 and urinary cotinine levels.
Lai HK; Hedley AJ; Repace J; So C; Lu QY; McGhee SM; Fielding R; Wong CM
Thorax; 2011 Jul; 66(7):615-23. PubMed ID: 21551212
[TBL] [Abstract][Full Text] [Related]
14. COPD in Chinese nonsmokers.
Zhou Y; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Wang X; Wang D; Liu S; Lu J; Zheng J; Zhong N; Ran P
Eur Respir J; 2009 Mar; 33(3):509-18. PubMed ID: 19251797
[TBL] [Abstract][Full Text] [Related]
15. IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung function.
Sadeghnejad A; Meyers DA; Bottai M; Sterling DA; Bleecker ER; Ohar JA
Am J Respir Crit Care Med; 2007 Oct; 176(8):748-52. PubMed ID: 17615386
[TBL] [Abstract][Full Text] [Related]
16. Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes.
Masuko H; Sakamoto T; Kaneko Y; Iijima H; Naito T; Noguchi E; Hirota T; Tamari M; Hizawa N
Int J Chron Obstruct Pulmon Dis; 2011; 6():181-9. PubMed ID: 21468164
[TBL] [Abstract][Full Text] [Related]
17. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
18. Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD.
DeMeo DL; Carey VJ; Chapman HA; Reilly JJ; Ginns LC; Speizer FE; Weiss ST; Silverman EK
Thorax; 2004 May; 59(5):396-400. PubMed ID: 15115866
[TBL] [Abstract][Full Text] [Related]
19. Perception of bronchoconstriction in smokers with airflow limitation.
Ottanelli R; Rosi E; Ronchi MC; Grazzini M; Lanini B; Stendardi L; Romagnoli I; Bertini S; Duranti R; Scano G
Clin Sci (Lond); 2001 Nov; 101(5):515-22. PubMed ID: 11672457
[TBL] [Abstract][Full Text] [Related]
20. [Functional measurements of the peripheral airways in COPD].
Garcia G; Perez T; Verbanck S
Rev Mal Respir; 2012 Feb; 29(2):319-27. PubMed ID: 22405121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
